贵州百灵：全资子公司糖宁通络片临床试验申请获批准

Core Viewpoint - Guizhou BaiLing's subsidiary BaiLing YuXiu has received approval from the National Medical Products Administration (NMPA) to conduct clinical trials for its drug, Tang Ning Tong Luo Pian, aimed at treating type 2 diabetes [1] Company Summary - Guizhou BaiLing's full subsidiary BaiLing YuXiu (Zhuhai) Pharmaceutical Co., Ltd. has been granted a Clinical Trial Approval Notice by NMPA [1] - The approved clinical trial is specifically for Tang Ning Tong Luo Pian, which is intended for use in type 2 diabetes treatment [1]